Albion Financial Group’s Novartis NVS Stock Holding History

Albion Financial Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44K	Hold	281	–	–	﹤0.01%	290
2026 Q1	$42.9K	Hold	281	–	–	﹤0.01%	281
2025 Q4	$38.7K	Hold	281	–	–	﹤0.01%	276
2025 Q3	$36K	Buy	281 +30	+12%	+$3.66K	﹤0.01%	285
2025 Q2	$30.4K	Hold	251	–	–	﹤0.01%	270
2025 Q1	$28K	Hold	251	–	–	﹤0.01%	282
2024 Q4	$24.4K	Buy	251 +160	+176%	+$17.1K	﹤0.01%	317
2024 Q3	$10.5K	Hold	91	–	–	﹤0.01%	331
2024 Q2	$9.69K	Hold	91	–	–	﹤0.01%	336
2024 Q1	$8.8K	Hold	91	–	–	﹤0.01%	327
2023 Q4	$9.19K	Hold	91	–	–	﹤0.01%	314
2023 Q3	$9.27K	Hold	91	–	–	﹤0.01%	303
2023 Q2	$9.18K	Hold	91	–	–	﹤0.01%	313
2023 Q1	$8.37K	Hold	91	–	–	﹤0.01%	316
2022 Q4	$8.26K	Hold	91	–	–	﹤0.01%	316
2022 Q3	$7K	Hold	91	–	–	﹤0.01%	331
2022 Q2	$8K	Sell	91 -90	-50%	-$7.9K	﹤0.01%	329
2022 Q1	$16K	Buy	181 +90	+99%	+$7.79K	﹤0.01%	335
2021 Q4	$8K	Hold	91	–	–	﹤0.01%	420
2021 Q3	$7K	Sell	91 -53	-37%	-$4.77K	﹤0.01%	395
2021 Q2	$13K	Buy	+144	New	+$12.8K	﹤0.01%	358
2020 Q4	$9K	Buy	+91	New	+$7.95K	﹤0.01%	358

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Albion Financial Group's NVS Position: Q2 2026 in Review

Albion Financial Group held its Novartis (NVS) position steady in Q2 2026 at 281 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #290.

Albion Financial Group first reported a position in NVS in Q4 2020 and has held it in 22 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Albion Financial Group held 281 shares of Novartis worth $44K as of Q2 2026.
Albion Financial Group left its Novartis share count unchanged in Q2 2026.
Novartis made up ﹤0.01% of Albion Financial Group's portfolio in Q2 2026, its #290 holding.
Albion Financial Group first reported a position in Novartis in Q4 2020 and has held it in 22 quarters since.
1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Albion Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.